Antibacterial activity and mechanism of action of chitosan nanofibers against toxigenic Clostridioides (Clostridium) difficile Isolates

被引:12
作者
Abadi, M. Shahini Shams [1 ]
Mirzaei, E. [2 ]
Bazargani, A. [2 ]
Gholipour, A. [3 ]
Heidari, H. [1 ]
Hadi, N. [1 ,4 ]
机构
[1] Shiraz Univ Med Sci, Sch Med, Dept Bacteriol & Virol, Zand St,Imam Hossein Sq, Shiraz, Iran
[2] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Med Nanotechnol, Shiraz, Iran
[3] Shahrekord Univ Med Sci, Cellular & Mol Res Ctr, Basic Hlth Sci Inst, Dept Microbiol & Immunol, Shahrekord, Iran
[4] Shiraz Univ Med Sci, Bioinformat & Computat Biol Res Ctr, Shiraz, Iran
来源
ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITA | 2020年 / 32卷 / 01期
关键词
Chitosan nanofibers; Clostridioides difficile; antibacterial effect; electron microscopy; atomic force microscopy; ANTIMICROBIAL RESISTANCE; NATURAL-PRODUCTS; EPIDEMIOLOGY; INFECTION; CHITIN; NANOPARTICLES; PATHOGENESIS; DIVERSITY; DIAGNOSIS; AGENTS;
D O I
10.7416/ai.2020.2332
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background. Clostridioides difficile a Gram-positive, obliged anaerobic, rod-shaped spore former bacterium, causes a wide spectrum of diseases, ranging from mild, self-limiting diarrhoea to serious diarrhea. Chitosan, a natural polysaccharide, is largely known for its activity against a wide range of microorganisms. Chitosan, in the form of nanofibrils (nanofibrilated chitosan), consists of separated fibers which can be suspended easily in aqueous media. Study design. This paper, for the first time, aims to evaluate the antimicrobial activity of chitosan nanofibers against C. difficile isolates. Methods. Chitosan nanofibers were characterized through scanning electron microscopy and atomic force microscopy. Minimum inhibitory concentration and minimum bactericidal concentration of chitosan nanofibers against toxigenic C. difficile isolates (with resistance gene: ennB, tetM and tetW) was determined by the standard broth microdilution method. Results. The Miniumum Inhibitory Concentration of chitosan nanofibers for two toxigenic isolates with resistance genes ermB, tetM and tetW, two toxigenic isolates ermB+ tetM+ and the standard strain ATCC 700057 was similar and equal to 0.25 mg/mL. The minimum bactericidal concentration for all isolates was 0.5 mg/mL. Conclusions. The results demonstrated that chitosan nanofibers exhibit potent antimicrobial activities against multiple toxigenic C. difficile isolates, and the antibacterial effect of chitosan nanofibers against C. difficile isolates with ennB, tetM and tetW resistance genes indicates that interfering with the synthesis of proteins is not the mechanism of action of chitosan nanofibers.
引用
收藏
页码:72 / 80
页数:9
相关论文
共 41 条
[1]   Clostridium difficile: Epidemiology, Pathogenesis, Management, and Prevention of a Recalcitrant Healthcare-Associated Pathogen [J].
Badger, Victor O. ;
Ledeboer, Nate A. ;
Graham, Mary Beth ;
Edmiston, Charles E., Jr. .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2012, 36 (06) :645-662
[2]   Antibacterial activity of chitin, chitosan and its oligomers prepared from shrimp shell waste [J].
Benhabiles, S. ;
Salah, R. ;
Lounici, H. ;
Drouiche, N. ;
Goosen, M. F. A. ;
Mameri, N. .
FOOD HYDROCOLLOIDS, 2012, 29 (01) :48-56
[3]   Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance [J].
Cassell, GH ;
Mekalanos, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (05) :601-605
[4]  
CLSIC L, 2018, 2018M100 CLSI, pM100
[5]   What is the role of antimicrobial resistance in the new epidemic of Clostridium difficile? [J].
Coia, John E. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 :S9-S12
[6]  
Dahl Eva Efsen, 2006, Ugeskr Laeger, V168, P1631
[7]   European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection [J].
Debast, S. B. ;
Bauer, M. P. ;
Kuijper, E. J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 :1-26
[8]   Antimicrobial susceptibility and resistance mechanisms of clinical Clostridium difficile from a Chinese tertiary hospital [J].
Dong, Danfeng ;
Zhang, Lihua ;
Chen, Xu ;
Jiang, Cen ;
Yu, Beiqin ;
Wang, Xuefeng ;
Peng, Yibing .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (01) :80-84
[9]   Burden of Clostridium difficile on the Healthcare System [J].
Dubberke, Erik R. ;
Olsen, Margaret A. .
CLINICAL INFECTIOUS DISEASES, 2012, 55 :S88-S92
[10]  
Dutta PK, 2004, J SCI IND RES INDIA, V63, P20